Testosterone Delivery Methods Compared: Injections vs Gels vs Pellets vs Patches

Intramuscular or subcutaneous injections (cypionate or enanthate) are the most common and cost-effective testosterone delivery method, providing the highest peak levels but with more fluctuation between doses. Topical gels (AndroGel, Testim) offer daily dosing with steadier levels but cost 5-10x more and carry a transfer risk to partners and children through skin contact. Pellets (Testopel) are implanted under the skin every 3-6 months for hands-off dosing but require a minor procedure and cannot be easily adjusted if the dose is wrong. Patches (Androderm) provide steady daily absorption but cause skin irritation in 30-60% of users and are falling out of favor. Most TRT patients start with injections because of cost, effectiveness, and dose flexibility.

Testosterone cypionate and enanthate are the two injectable esters used in TRT. Both are dissolved in oil (typically cottonseed or sesame oil) and injected intramuscularly (thigh or glute) or subcutaneously (abdomen or thigh fat). The ester determines the half-life: cypionate has a half-life of approximately 8 days, enanthate about 7 days. Both support weekly or biweekly dosing, though weekly injections provide more stable levels. Typical dosing: 100-200 mg per week, adjusted based on trough testosterone levels (measured the morning before the next injection). The goal for most TRT protocols is a trough level of 500-700 ng/dL, with peak levels reaching 800-1,200 ng/dL about 24-48 hours after injection. This peak-to-trough fluctuation is the main downside of injections — some patients feel energized after injection and sluggish before the next dose. Splitting the weekly dose into two injections (every 3.5 days) significantly reduces this fluctuation. Subcutaneous injection has become increasingly popular because it uses a smaller needle (27-29 gauge vs 22-25 gauge for IM), is less painful, produces slightly less peak-to-trough variation, and patients can do it themselves without contorting to reach their glute. Multiple studies (including Al-Futaisi et al., 2006 and Spratt et al., 2017) have shown equivalent testosterone levels between subQ and IM routes at the same dose. Cost is the biggest advantage: testosterone cypionate costs $30-80 per month through most pharmacies with a prescription, and significantly less through compounding pharmacies. This makes it the most accessible option by far. Dosed tracks injection schedules with half-life-aware reminders and site rotation logging for both IM and subQ protocols. This content is for educational purposes only and does not constitute medical advice. TRT requires medical supervision, regular blood work, and ongoing provider management.

Testosterone gels (AndroGel 1% and 1.62%, Testim 1%, Vogelxo, generic formulations) are applied daily to the shoulders, upper arms, or abdomen. The testosterone absorbs through the skin over several hours, providing relatively steady blood levels without the peaks and troughs of weekly injections. The pharmacokinetics are attractive in theory: once steady state is reached (usually within 2-3 weeks of daily application), testosterone levels remain within a 15-20% range throughout the day — much flatter than injections. This stability is the primary clinical argument for gels over injections. The practical downsides are significant. First, cost: brand-name gels run $300-600 per month without insurance. Even generic versions cost $100-200 per month — still 3-5x more than injectable cypionate. Second, transfer risk: the testosterone in the gel can transfer to anyone who touches the application site, including partners and children. Children exposed to testosterone gel have developed precocious puberty — this prompted an FDA black box warning. You must wash your hands after application, cover the area with clothing, and avoid skin-to-skin contact at the application site for at least 6 hours. Third, absorption variability: absorption through the skin varies by 20-40% between individuals depending on skin thickness, body fat, sweat, and whether you shower too soon after application. Some men absorb gels well and achieve therapeutic levels. Others apply the same dose and never reach adequate blood levels — a frustrating discovery that usually takes 6-8 weeks of testing to confirm. Gels work best for patients who cannot self-inject, want daily dosing for stable levels, and are willing to pay the premium and manage the transfer risk. They are a poor choice for men with young children at home or those who share a bed with a partner without strict site management.

Testosterone pellets (Testopel is the most common brand) are small, compressed cylinders of crystalline testosterone implanted under the skin of the hip or buttock through a minor in-office procedure. Each pellet is about the size of a grain of rice and dissolves slowly over 3-6 months, releasing testosterone at a relatively steady rate. The appeal is convenience: no daily application, no weekly injection, no remembering your dose. Once the pellets are in, you do nothing until they need to be replaced. Levels are reasonably stable — more so than biweekly injections but not perfectly flat. Most patients receive 8-14 pellets per insertion depending on their dose requirements. The downsides are less discussed but real. The insertion procedure, while minor, requires local anesthesia, a small incision, and a specialized trocar to place the pellets. There is a 5-10% complication rate including pellet extrusion (a pellet works its way back out through the incision — requires replacement), infection at the insertion site, and pain or bruising. You also cannot easily adjust the dose once the pellets are in — if the dose is too high, you wait it out. If too low, you get another insertion. Cost is moderate: $300-900 per insertion depending on the number of pellets, billed 2-4 times per year. This is more expensive than injections but comparable to or less than gels on an annualized basis. Insurance coverage is inconsistent. Pellets work best for patients who are already on a stable dose (proven through months of injection or gel therapy), dislike the routine of regular dosing, and are comfortable with a minor procedure every few months.

Testosterone patches (Androderm) are applied to the skin daily, typically on the back, thigh, upper arm, or abdomen. They provide steady absorption similar to gels but without the transfer risk — the testosterone is contained within the patch. The pharmacokinetics mimic the natural circadian rhythm, with levels peaking in the morning and declining by evening. The major problem: skin irritation. Studies report that 30-60% of patch users develop contact dermatitis (redness, itching, blistering) at the application site. Rotating sites helps but does not eliminate the problem for most affected users. This high irritation rate has made patches the least popular TRT delivery method despite their pharmacokinetic advantages. Nasal testosterone (Natesto) is applied inside the nostrils 2-3 times daily. It avoids the skin transfer issue and produces rapid absorption, but the frequent dosing is inconvenient and the nasal application is awkward. Oral testosterone undecanoate (Jatenzo, Tlando) was approved in 2019 — the first effective oral testosterone in the U.S. It must be taken twice daily with food (fat is required for absorption). Cost is high ($400-700/month) and the twice-daily food requirement limits compliance. Dosed supports protocol tracking for all testosterone delivery methods including injection scheduling, gel application reminders, pellet replacement dates, and patch rotation patterns. The app tracks your specific method and can visualize expected blood level curves based on your dose and timing.